Sangamo Therapeutics
SGMO
#10416
Rank
A$43.8 M
Marketcap
A$0.11
Share price
0.00%
Change (1 day)
-85.86%
Change (1 year)

Sangamo Therapeutics (SGMO) - Net assets

Net assets on the balance sheet as of March 2026 : -A$27.09 Million

According to Sangamo Therapeutics 's latest financial reports the company has -A$27.09 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sangamo Therapeutics - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-A$21.31 Million-158.19%
2024-12-31$A$36.6 M-69.91%
2023-12-31$A$0.12 B-71.93%
2022-12-31$A$0.43 B-16.28%
2021-12-31$A$0.51 B-19.96%
2020-12-31$A$0.64 B4.65%
2019-12-31$A$0.61 B18.56%
2018-12-31$A$0.52 B116.6%
2017-12-31$A$0.24 B27.38%
2016-12-31$A$0.18 B-28.47%
2015-12-31$A$0.26 B4.62%
2014-12-31$A$0.25 B85.04%
2013-12-31$A$0.13 B118.5%
2012-12-31$A$62.44 M-20.09%
2011-12-31$A$78.15 M41.99%
2010-12-31$A$55.03 M-31.12%
2009-12-31$A$79.9 M1.77%
2008-12-31$A$78.51 M-4.82%
2007-12-31$A$82.49 M33.52%
2006-12-31$A$61.78 M19.55%
2005-12-31$A$51.67 M23.52%
2004-12-31$A$41.83 M-30.37%
2003-12-31$A$60.08 M-37.6%
2002-12-31$A$96.28 M-40.33%
2001-12-31$A$0.16 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
A$116.00 B-428,409.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.13 B-48,583.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$26.65 B-98,499.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
A$23.95 B-88,535.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$33.48 B-123,713.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$65.63 B-242,416.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.53 B-5,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$8.87 B-32,872.94%๐Ÿ‡บ๐Ÿ‡ธ USA